$4.2mill revenue for the financial year. Below $5mill but still...

$4.2mill revenue for the financial year. Below $5mill but still a good performance when looking at trends. March quarter revenue was $685K, for 9 months was $2.7mill so this quarter it was around $1.5mill. Considering last quarter expenditure was $1.5mill and they've just implemented cost-cutting measures, it looks like we're about to move into profitable territory.

Now all we need are updates on the current trials in China. Progress looks positive to me.